Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients "Flo 24"

Completed

Phase 1 Results N/A

Summary of Purpose

The purpose of this study is to assess the safety and feasibility of the NeuroFlo™ catheter in treating patients with ischemic stroke whose last time symptom-free was between 8-24 hours prior to treatment. The NeuroFlo device is intended to increase blood flow to the brain and potentially reduce the damage caused by stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 February 2009.

1 Feb 2007 16 Feb 2007 1 Jan 2009 1 Jan 2009 1 Feb 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment

Contacts

  • Lori Austin (763) 315-1809

    info@coaxia.com